REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Octo Pharma Kft. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: Octo Pharma Kft. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Octo Pharma Kft. is an enterprise in Hungary, with the main office in Budapest. The enterprise currently operates in the Pharmacies and Drug Stores sector. It was established on May 16, 2008. Octo Pharma Kft. currently employs 34 (2024) people. From the latest financial highlights, Octo Pharma Kft. reported a net sales revenue increase of 18% in 2023. A growth of 0.12% was recorded in its total assets. In 2023, Octo Pharma Kft.’s net profit margin increased by 0.06%.

Headquarters
Mikszath K. ter 4.
Budapest; Budapest; Postal Code: 1088

Contact Details: Purchase the Octo Pharma Kft. report to view the information.

Basic Information
Total Employees:
Purchase the Octo Pharma Kft. report to view the information.
Outstanding Shares:
Purchase the Octo Pharma Kft. report to view the information.
Registered Capital:
Purchase the Octo Pharma Kft. report to view the information.
Financial Auditors:
Purchase the Octo Pharma Kft. report to view the information.
Incorporation Date:
May 16, 2008
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Octo Pharma Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
18%▲
Total operating revenue
18.01%▲
Operating profit (EBIT)
26.03%▲
EBITDA
27.81%▲
Net Profit (Loss) for the Period
20.38%▲
Total assets
0.12%▲
Total equity
18.22%▲
Operating Profit Margin (ROS)
0.21%▲
Net Profit Margin
0.06%▲
Return on Equity (ROE)
0.47%▲
Quick Ratio
0.52%▲
Cash Ratio
0.03%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo